Brand:
Dragon Pharma, Europe
Manufacturer:
Dragon Pharma, Europe
Dosage Info:
<div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel">
<section class="tab-panel" id="panel-usage">
<h2>Dosage & Usage Guidelines</h2>
<p>BPC 157 is administered subcutaneously or intramuscularly, depending on the treatment area. While clinical dosing protocols are not yet established, anecdotal protocols typically suggest:</p>
<ul>
<li>200–500 mcg daily</li>
<li>Cycle duration: 2–4 weeks depending on injury severity or intended use</li>
</ul>
<p>Many users integrate BPC 157 into broader recovery or post-surgical protocols to aid healing and reduce downtime.</p>
<h3>Potential Benefits of BPC 157</h3>
<ul>
<li>Accelerated tendon and ligament repair</li>
<li>Reduced inflammation and joint pain</li>
<li>Improved gut healing (especially for ulcers or IBS symptoms)</li>
<li>Faster recovery from muscle tears or surgery</li>
</ul>
<p>Clinical studies, such as those published in the <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504390/" rel="noopener nofollow" target="_blank">National Library of Medicine</a>, continue to evaluate BPC 157's role in tissue regeneration and injury healing mechanisms.</p>
<h3>Does BPC 157 Require Post-Cycle Therapy (PCT)?</h3>
<p>No. Since BPC 157 is not a hormonal compound, it does not suppress testosterone or impact the endocrine system. As such, it does not require PCT when used alone. However, if used alongside other performance-enhancing compounds, users should assess overall hormonal impact and plan accordingly.</p>
<h3>Why Choose Dragon Pharma BPC 157?</h3>
<p><strong>Dragon Pharma</strong> offers high-purity peptides backed by independent lab tests. Each vial of BPC 157 is produced under pharmaceutical-grade conditions, ensuring consistency and accuracy in dosing. As an <a href="/">official Dragon Pharma supplier</a>, our store guarantees batch-tested authenticity with every order.</p>
<h3>Example of a BPC 157 Cycle</h3>
<ul>
<li><strong>Weeks 1–4:</strong> 250–500 mcg daily (subcutaneous, near injury site)</li>
<li><strong>Optional:</strong> Combine with <a href="https://www.dragonpharma.net/injectables-391/cypionat-2917">Testosterone Cypionate</a> during a recovery-based AAS cycle</li>
</ul>
</section>
</div>
Technical Details
Peptide Type
Synthetic Pentadecapeptide
Peptide Sequence
GEPPPGKPADDAGLV
Peptide Length
15 Amino Acids
Molecular Formula
C₆₂H₉₈N₁₆O₂₂
Molecular Weight
1419.5 g/mol
Terminal Form
Free N- and C-Termini
Development Status
Investigational
